The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Radium-223 without androgen deprivation therapy (ADT) in patients (Pts) with biochemically recurrent prostate cancer (BCR) and PET findings in the bones.
 
Melissa Abel
No Relationships to Disclose
 
Fatima Karzai
No Relationships to Disclose
 
Philip Arlen
Employment - Leidos Biomedical Research; Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
Patents, Royalties, Other Intellectual Property - have patents held by Precision Biologics
 
Clara Chen
No Relationships to Disclose
 
Esther Mena
No Relationships to Disclose
 
Liza Lindenberg
No Relationships to Disclose
 
Jeanny Aragon-Ching
Honoraria - Astellas Scientific and Medical Affairs Inc; Bristol-Myers Squibb; EMD Serono; Merck KGaA; Merck/Pfizer; Pfizer/EMD Serono
Consulting or Advisory Role - Algeta/Bayer; Amgen; AstraZeneca; AstraZeneca; AstraZeneca/MedImmune; AVEO; Bayer; Dendreon; EMD Serono; Exelixis; Immunomedics; Janssen Biotech; Merck; Novartis; Pfizer; Pfizer/Myovant; Sanofi; Seagen
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Janssen-Ortho; Seattle Genetics/Astellas; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Algeta/Bayer; Astellas Pharma; Bristol Myers Squibb; Dendreon; EMD Serono
 
Aanika Warner
No Relationships to Disclose
 
Frank Lin
No Relationships to Disclose
 
Lisa Cordes
No Relationships to Disclose
 
Katherine Lee-Wisdom
No Relationships to Disclose
 
Megan Hausler
No Relationships to Disclose
 
Amy Hankin
Stock and Other Ownership Interests - Amgen; Medtronic
 
Monique Williams
No Relationships to Disclose
 
Yolanda McKinney
No Relationships to Disclose
 
James Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Marengo Therapeutics (Inst); Merck (Inst); NextCure (Inst); PDS Biotechnology (Inst); Precigen (Inst); Syndax (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES Publication number: 20200062849 Abstract: The invention provides a method of inhibiting a malignancy associated with human papilloma virus (HPV) comprising administering to a subje
 
William Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); Propella Therapeutics (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Aryl Hydantoin Hetercycles and Methods of Making and Using Thereof NIH and HHS Reference No. E-169-2018-0 US Provisional Application filed in 2019 License to Novartis Institutes for BioMedical Research (Inst); Aza-Epoxy-guaiane Derivatives and Treatment of Cancer NIH and HHS Reference No. E-090-2014/2-US-05) European Patent No. 3102581, filed 05/02/2018 U.S. Provisional Patent Application No. 62/018,381, filed 06/27/2014 PCT Application No. PCT/US2015/014601 (Inst); Epidithiodiketopiperazine Analogs and Methods of Use NIH and HHS Reference No. E-089-2023-0-PC-01 U.S. PCT Patent Application No. PCT/US2024/032744, filed 06/06/2024 (Inst); Hypoxia Inducible Factor 1 (HIF-1) Inhibitors NIH and HHS Reference No. E-115-2015/0-US-01 U.S. Provisional Application No. 62/144,182 filed 04/07/2015 U.S. Patent No. 10,246,463 issued 4/2/2019 (Inst); SLCO1B3 genotype NIH and HHS Reference No.: E-083-2007/0-EIR-00) US Provisional Application No.: 60/879,503 (E-083-2007/0-US-01) Filed application provisional 01/08/2007 PCT Appliciaton: PCT/US2008/000310 Filed application international 01/08/2008 Nati (Inst); Thalidomide Analogs and Methods of Use NIH and HHS Reference No. E-208-2015/0-US-01 U.S. Patent Application No 62/235,105, filed 09/30/2015 U.S. Patent Application No. 15/765,193, filed 03/28/2018 Patent No. 10,730,835 (USA, Australia, Canada, Europe, (Inst); Thalidomide Analogs and Methods of Use NIH and HHS Reference No. E-208-2015/0-US-01 U.S. Patent Application No 62/235,105, filed 09/30/2015 U.S. Patent Application No. 15/765,193, filed 03/28/2018 Patent No. 10,730,835 (USA, Australia, Canada, Europe, (Inst)
 
Peter Choyke
No Relationships to Disclose
 
Ravi Madan
No Relationships to Disclose